Litigation
ALJ Delay Case Status Report and Dashboard - Sept. 28, 2021
UNITED STATES DISTRICT COURT
FOR THE DISTRICT OF COLUMBIA
AMERICAN HOSPITAL ASSOCIATION, et al.,
Plaintiffs,
The United States Supreme Court this morning rejected the third major challenge to the Affordable Care Act, holding in a 7-2 decision that the challengers did not have “standing,” or the legal right to challenge the portions of the ACA they alleged were unconstitutional.
IN THE
Supreme Court of the United States
THE AMERICAN HOSPITAL ASSOCIATION, et al.,
Petitioners,
v.
XAVIER BECERRA, in his official capacity as the Secretary of Health and Human Services, et al.,
Respondents.
On Petition for a Writ of Certiorari to the
United States Court of Appeals
for the…
IN THE
Supreme Court of the United States
_________
AMERICAN HOSPITAL ASSOCIATION, ET AL.,
Petitioners,
v.
XAVIER BECERRA, IN HIS OFFICIAL CAPACITY
AS SECRETARY OF HEALTH AND
HUMAN SERVICES,
Respondent.
On Petition for a Writ of Certiorari
to the United States Court of Appeals
for the District…
Hospital Associations support challenge to conditions placed on hospital affiliation.
The AHA and Texas Hospital Association filed a friend-of-the-court brief supporting the Texas Health and Human Services Commission and several Texas hospitals and health systems challenging a U.S. Department of Health and Human Services’ Departmental Appeals Board decision adopting a “net effect”…
UNITED STATES DISTRICT COURTFOR THE DISTRICT OF COLUMBIAAMERICAN HOSPITAL ASSOCIATION, et al., Plaintiffs
QUESTION PRESENTED: The question presented is whether Chevron deference permits HHS to set reimbursement rates based on acquisition cost and vary such rates by hospital group if it has not collected adequate hospital acquisition cost survey data.
A federal appeals court today ruled against AHA’s legal challenge to the Centers for Medicare & Medicaid Services’ (CMS) final rule mandating that hospitals disclose their privately negotiated charges with commercial health insurers. The rule goes into effect Jan. 1, 2021.